Status:
WITHDRAWN
Thoracic Kyphosis and Osteoporosis: Study of Their Relationship With Respiratory Functions in Chronic Obstructive Pulmonary Disease.
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Conditions:
COPD
Osteoporosis
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a condition characterized by a progressive and incompletely reversible limitation of airborne gas flow . The association of co-morbidities with COPD and...
Detailed Description
Osteoporosis, characterized by bone quality disorders and low bone mineral density (BMD) leading to a high risk of fractures, is common in COPD patients. For example, studies have reported OP rates ra...
Eligibility Criteria
Inclusion
- Man or woman age \> 40
- FEV1/CVF ratio \< 0.7 as defined by the Global Initiative for Chronic Obstruction Lung Disease (GOLD).
- Moderate to severe COPD as defined by GOLD (grade C and D)
Exclusion
- Presence of metal or plastic parts in the field of examination
- Pregnancy
- Patients who are not affiliated with or do not benefit from a social security system
- Person under guardianship or curatorship
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04757714
Start Date
June 1 2023
End Date
June 1 2025
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR d'ORLEANS
Orléans, France, 45067